new glp 1 gip GLP-1 vs. GLP-1 + GIP: What's the Difference for your Metabolism? Frontiers | Clinical perspectives on

There is a need to consider the possibility that DPP4 inhibitors may impact the immune response and potentially increase the risk of infections in general

A systematic review of case reports found that liraglutide was among the most frequently used medications in pancreatitis cases reported ( Our results with respect to the risk of pancreatitis with semaglutide and liraglutide support a study done by Marso et al

In clinical studies , adults with obesity or overweight (without type 2 diabetes) who took Wegovy lost around 15% of their body weight over 68 weeks

In animal models, GLP-1 agonists have been shown to significantly delay the onset and severity of experimental autoimmune encephalopathy symptoms, as well as to increase nerve myelination and brain weight

Antibiotics induced intestinal tight junction barrier dysfunction is associated with microbiota dysbiosis, activated NLRP3 inflammasome and autophagy

It acts on receptors in the hypothalamus and brainstem to promote satiety and reduce food intake